AU Inc. is a leading developer of millimeter-wave based radar sensors for automotive sectors. Our technological strength lies in the detection of lifeforms, especially humans in cars. AU independently develops a wide range of algorithms from in-cabin radar signal processing to imaging radar module for autonomous vehicles.
Alteogen Inc.
Alteogen Inc. is a biotechnology company based in Korea dedicated to developing novel biologics for better life. Our pipeline includes novel hyaluronidase, next-generation long-acting therapeutic proteins, antibody-drug conjugate (ADC) and biosimilars. | Alteogen Inc. is a South Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-Drug Conjugates (ADCs), biobetters, and biosimilars. Alteogen’s portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP™-fusion and NexMab™ platform technology, respectively. It also developed a proprietary recombinant human hyaluronidase enzyme utilizing Hybrozyme™ technology, which enables the large volume subcutaneous administration of drugs that are typically administered as an IV infusion. The company was founded in 2008 and listed on KOSDAQ (196170.KQ).